For decades, chronic respiratory disease management has been built around reacting to crises rather than preventing them.
The problem is not that the body fails to signal distress. The problem is that historically, healthcare systems have lacked scalable ways to continuously understand and respond to those signals in real life.
Sharon Samjitsingh
CEO, Health Care Originals, Inc.
Asthma and COPD remain among the leading drivers of avoidable emergency department visits, hospitalizations, missed work and school days, and long-term healthcare spending. Yet most care models still rely on episodic snapshots: clinic visits, symptom recall, or intervention after deterioration has already become severe. That’s a system-level view.
But, for people with these conditions and those who love them, the result is an almost complete lack of peace of mind. This is my lived experience. I had several near death experiences despite doing everything I was told to do. For me and my family — there was no peace of mind — we lived in almost constant fear of when the next attack would happen.
At Health Care Originals (HCO), we believe the future of respiratory care begins with a simple but transformative idea:
The body is already signaling. We built the technology to finally listen consistently.
Our platform combines proprietary physiologic sensing, AI-driven intelligence, and therapist-guided care to identify subtle changes in respiratory health before they escalate into crises. Instead of waiting for an exacerbation to become obvious, we continuously monitor patterns in breathing, cough, and deep organ acoustics to detect deterioration earlier and intervene proactively.
This shift from reactive care to continuous physiologic intelligence has profound implications for both patients and healthcare systems.
For patients, it means more control. More control means a life of fewer exacerbations, greater confidence, and peace of mind.
For healthcare organizations, employers, and payers, it means:
- lower avoidable utilization,
- reduced total cost of care,
- improved engagement,
- and more scalable chronic disease management.
Importantly, proactive respiratory care is not simply about technology. Human support remains essential. We are all very familiar with the 10 minutes of 1:1 time we get with a physician. This leaves little room for educating patients on the things they need to do in addition to medication adherence; the things they need to really become experts at managing their care.
That’s why HCO’s model combines intelligent technology with compassionate clinical support from respiratory therapists who help patients understand what their bodies are signaling and what actions to take before conditions worsen.
We are already seeing the impact of this approach through validated outcomes, payer partnerships, and growing deployment across respiratory populations. Healthcare must shift to earlier intervention, and continuous respiratory intelligence will become foundational infrastructure rather than an optional enhancement.
At HCO we also see a future of care everywhere. But the conversation around care must be anchored in reducing the cost of healthcare, and that’s where we excel. When your solution works, participating in value-based approaches and outcomes-based payment models is straightforward, and we are proud to lead the industry with our game-changing graduation promise that assures our employer and payer partners of increasing ROI.
The future of respiratory care is here. It’s proactive, personalized, and continuous.
And most importantly, it will help people spend less time navigating disease and more time living their lives.
To learn more, visit healthcareoriginals.com
